← Back to Search

Behavioral Intervention

Prehabilitation for Colorectal Cancer

Q: What is the number of participants enrolled in this trial?

<p>Absolutely. According to the clinicaltrials.gov listings, this trial is open for recruitment at this time and was initially posted on January 31st 2022 before being edited last August 11th 2023. The study seeks 60 participants from 1 distinct medical site.</p>

Q: Is the enrollment window for this research still open?

<p>Affirmative. Clinicaltrials.gov clearly states that the recruitment process for this trial is ongoing, with its inaugural post date of January 31st 2022 and most recent update on August 11th 2023. 60 patients are sought from a single medical centre.</p>

N/A

Recruiting

Led By Chelsia Gillis, RD PhD

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from date of baseline assessment until date of surgery,an average of 4 weeks, recorded in steps

Awards & highlights

Study Summary

This trial found that 60% of older colorectal cancer patients w/ poor physical function couldn't reach pre-op walking goal. Malnutrition was linked to worse functioning & more than twice as many <400m patients were malnourished. Nutritional deficiency may prevent reaching walking goal & improve outcomes.

Who is the study for?

This trial is for older adults (65+) with colorectal cancer who are malnourished and have a low walking distance (less than 400m in six minutes). They must be scheduled for surgery but not have metastatic cancer or conditions like dementia, Parkinson's, or stroke that would make exercise unsafe.Check my eligibility

What is being tested?

The study tests if improving nutrition alone can help patients walk farther before surgery. It focuses on those unable to meet the pre-surgery walking goal despite usual prehabilitation, which includes nutrition, exercise, and mental support.See study design

What are the potential side effects?

Since this trial involves nutritional interventions and exercise programs rather than medications, side effects may include muscle soreness from physical activity and potential gastrointestinal changes due to diet adjustments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of baseline assessment until date of surgery,an average of 4 weeks, recorded in steps

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of baseline assessment until date of surgery,an average of 4 weeks, recorded in steps

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of baseline assessment until date of surgery,an average of 4 weeks, recorded in steps for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Preoperative six-minute walking distance

Secondary outcome measures

Adherence to the exercise intervention

Adherence to the nutrition intervention

Trial Design

2Treatment groups

Experimental Treatment

Group I: Nutrition onlyExperimental Treatment1 Intervention

The nutrition intervention will be based on a comprehensive nutrition assessment by a dietitian at baseline, enabling individualized caloric and protein targets.

Group II: Nutrition and exerciseExperimental Treatment2 Interventions

The nutrition intervention will be based on a comprehensive nutrition assessment by a dietitian at baseline, enabling individualized caloric and protein targets. The exercise intervention will be personalized based on a comprehensive assessment to include both a resistance and an aerobic component in the form of a "snack".

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nutrition

2011

Completed Phase 3

~58070

Exercise

2016

Completed Phase 1

~760

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor

395 Previous Clinical Trials

999,317 Total Patients Enrolled

6 Trials studying Malnutrition

20,010 Patients Enrolled for Malnutrition

McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER

447 Previous Clinical Trials

159,692 Total Patients Enrolled

1 Trials studying Malnutrition

1,760 Patients Enrolled for Malnutrition

Chelsia Gillis, RD PhDPrincipal InvestigatorMcGill University

Media Library

Prehabilitation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05999370 — N/A

Malnutrition Research Study Groups: Nutrition and exercise, Nutrition only

Malnutrition Clinical Trial 2023: Prehabilitation Highlights & Side Effects. Trial Name: NCT05999370 — N/A

Prehabilitation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05999370 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the number of participants enrolled in this trial?

"Absolutely. According to the clinicaltrials.gov listings, this trial is open for recruitment at this time and was initially posted on January 31st 2022 before being edited last August 11th 2023. The study seeks 60 participants from 1 distinct medical site."

Answered by AI

Is the enrollment window for this research still open?

"Affirmative. Clinicaltrials.gov clearly states that the recruitment process for this trial is ongoing, with its inaugural post date of January 31st 2022 and most recent update on August 11th 2023. 60 patients are sought from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition

Chelsia Ann Gillis 2022. "Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05999370.